Is PT-141 FDA approved?
Yes, as Vyleesi, only for low sexual desire that causes distress (hypoactive sexual desire disorder) in women who have not reached menopause. That is based on studies with more than 1,200 people. The approval covers only that one group and use. Using it outside that, including in men, is off-label or through the unapproved research chemical market.
Every FDA-approved compound in the archive, as a list
Studies in people from the compound pages this answer belongs to
- PT-141
- Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials (RECONNECT) 2019 PMID 31599840
- Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder 2019 PMID 31599847
- Usefulness of ambulatory blood pressure monitoring to assess the melanocortin receptor agonist bremelanotide 2017 PMID 27977473
Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.
Part of sexual health and hormone peptides. PT-141, melanotan, oxytocin, gonadorelin, and kisspeptin-10.